Citations (17)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Federica Sotgia, Diana Whitaker-Menezes, Ubaldo E. Martinez-Outschoorn, Ahmed F. Salem, Aristotelis Tsirigos, Rebecca Lamb, Sharon Sneddon, James Hulit, Anthony Howell & Michael P. Lisanti. (2012) Mitochondria “fuel” breast cancer metabolism: Fifteen markers of mitochondrial biogenesis label epithelial cancer cells, but are excluded from adjacent stromal cells. Cell Cycle 11:23, pages 4390-4401.
Read now
Read now
Articles from other publishers (16)
Versha Tripathi, Pooja Jaiswal, Khageswar Sahu, Shovan Kumar Majumder, Dharmendra Kashyap, Hem Chandra Jha, Amit Kumar Dixit & Hamendra Singh Parmar. (2022) Repurposing of metabolic drugs and mitochondrial modulators as an emerging class of cancer therapeutics with a special focus on breast cancer. Advances in Cancer Biology - Metastasis 6, pages 100065.
Crossref
Crossref
Fabian Stuhldreier, Laura Schmitt, Thomas Lenz, Ilka Hinxlage, Marcel Zimmermann, Philipp Wollnitzke, Julian Schliehe-Diecks, Yang Liu, Paul Jäger, Stefanie Geyh, Nicole Teusch, Christoph Peter, Sanil Bhatia, Rainer Haas, Bodo Levkau, Andreas S. Reichert, Kai Stühler, Peter Proksch, Björn Stork & Sebastian Wesselborg. (2022) The mycotoxin viriditoxin induces leukemia- and lymphoma-specific apoptosis by targeting mitochondrial metabolism. Cell Death & Disease 13:11.
Crossref
Crossref
Theia Lelcu, Anca M. Bînă, Maria D. Dănilă, Călin M. Popoiu, Oana M. Aburel, Smaranda T. Arghirescu, Claudia Borza & Danina M. Muntean. (2021) Assessment of Platelet Mitochondrial Respiration in a Pediatric Population: A Pilot Study in Healthy Children and Children with Acute Lymphoblastic Leukemia. Children 8:12, pages 1196.
Crossref
Crossref
Svetlana B. Panina, Jingqi Pei & Natalia V. Kirienko. (2021) Mitochondrial metabolism as a target for acute myeloid leukemia treatment. Cancer & Metabolism 9:1.
Crossref
Crossref
Elise Aasebø, Frode S. Berven, Randi Hovland, Stein Ove Døskeland, Øystein Bruserud, Frode Selheim & Maria Hernandez-Valladares. (2020) The Progression of Acute Myeloid Leukemia from First Diagnosis to Chemoresistant Relapse: A Comparison of Proteomic and Phosphoproteomic Profiles. Cancers 12:6, pages 1466.
Crossref
Crossref
Aritri Ghosh, Kabita Chatterjee, Amit Roy Chowdhury & Ananya Barui. (2020) Clinico-pathological significance of Drp1 dysregulation and its correlation to apoptosis in oral cancer patients. Mitochondrion 52, pages 115-124.
Crossref
Crossref
A. PETRUȘ, D. LIGHEZAN, M. DĂNILĂ, O. DUICU, A. STURZA, D. MUNTEAN & I. IONIȚĂ. (2019) Assessment of Platelet Respiration as Emerging Biomarker of Disease. Physiological Research, pages 347-363.
Crossref
Crossref
Shanshan Pei, Mohammad Minhajuddin, Biniam Adane, Nabilah Khan, Brett M. Stevens, Stephen C. Mack, Sisi Lai, Jeremy N. Rich, Anagha Inguva, Kevin M. Shannon, Hyunmin Kim, Aik-Choon Tan, Jason R. Myers, John M. Ashton, Tobias Neff, Daniel A. Pollyea, Clayton A. Smith & Craig T. Jordan. (2018) AMPK/FIS1-Mediated Mitophagy Is Required for Self-Renewal of Human AML Stem Cells. Cell Stem Cell 23:1, pages 86-100.e6.
Crossref
Crossref
Micol Ravà, Aleco D’Andrea, Paola NicoliIlaria GrittiGiulio DonatiMirko DoniMarco Giorgio, Daniela OliveroBruno Amati. (2018)
Therapeutic synergy between tigecycline and venetoclax in a preclinical model of
MYC
/
BCL2
double-hit B cell lymphoma
. Science Translational Medicine 10:426.
Crossref
Crossref
Zhijie Xu, Yuanliang Yan, Zhi Li, Long Qian & Zhicheng Gong. (2016) The Antibiotic Drug Tigecycline: A Focus on its Promising Anticancer Properties. Frontiers in Pharmacology 7.
Crossref
Crossref
Gregory A. Reed, Gary J. Schiller, Suman Kambhampati, Martin S. Tallman, Dan Douer, Mark D. Minden, Karen W. Yee, Vikas Gupta, Joseph Brandwein, Yulia Jitkova, Marcela Gronda, Rose Hurren, Aisha Shamas‐Din, Andre C. Schuh & Aaron D. Schimmer. (2016) A Phase 1 study of intravenous infusions of tigecycline in patients with acute myeloid leukemia. Cancer Medicine 5:11, pages 3031-3040.
Crossref
Crossref
CHENGLONG LI, BIAO ZHU, JIAO CHEN & XIAOBING HUANG. (2016) Feature genes predicting the FLT3/ITD mutation in acute myeloid leukemia. Molecular Medicine Reports 14:1, pages 89-94.
Crossref
Crossref
Xiaonan Zhang, Angelo de Milito, Maria Olofsson, Joachim Gullbo, Padraig D’Arcy & Stig Linder. (2015) Targeting Mitochondrial Function to Treat Quiescent Tumor Cells in Solid Tumors. International Journal of Molecular Sciences 16:11, pages 27313-27326.
Crossref
Crossref
Rebecca Lamb, Gloria Bonuccelli, Béla Ozsvári, Maria Peiris-Pagès, Marco Fiorillo, Duncan L. Smith, Generoso Bevilacqua, Chiara Maria Mazzanti, Liam A. McDonnell, Antonio Giuseppe Naccarato, Maybo Chiu, Luke Wynne, Ubaldo E. Martinez-Outschoorn, Federica Sotgia & Michael P. Lisanti. (2015) Mitochondrial mass, a new metabolic biomarker for stem-like cancer cells: Understanding WNT/FGF-driven anabolic signaling. Oncotarget 6:31, pages 30453-30471.
Crossref
Crossref
Yulia Jitkova, Marcela Gronda, Rose Hurren, Xiaoming Wang, Carolyn A. Goard, Bozhena Jhas & Aaron D. Schimmer. (2014) A Novel Formulation of Tigecycline Has Enhanced Stability and Sustained Antibacterial and Antileukemic Activity. PLoS ONE 9:5, pages e95281.
Crossref
Crossref
Hamendra Singh Singh Parmar, Versha Tripathi, Pooja Jaiswal, Khageshwar Sahu, Shovan Kumar Majumder, Dharmendra Kashyap, Amit Kumar Dixit & Hem Chandra Jha. (2022) Repurposing of Metabolic Drugs and Mitochondrial Modulators as an Emerging Class of Cancer Therapeutics with a Special Focus on Breast Cancer. SSRN Electronic Journal.
Crossref
Crossref